Cargando…

SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative Review

INTRODUCTION: The obesity epidemic is closely linked to the rising prevalence of type 2 diabetes (T2D). Body weight reduction remains an important challenge in patients with T2D, as it requires changing their overall metabolic control. Of all glucose-lowering therapies, only sodium–glucose cotranspo...

Descripción completa

Detalles Bibliográficos
Autores principales: Janež, Andrej, Fioretto, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342745/
https://www.ncbi.nlm.nih.gov/pubmed/34244976
http://dx.doi.org/10.1007/s13300-021-01104-z